[Abstract] Recent advances in Next Generation Sequencing (NGS) technologies have given an impetus to find causality for rare genetic disorders. Since 2005 and aftermath of the human genome project, efforts have been made to understand the rare variants of genetic disorders. Benchmarking the bioinformatics pipeline for whole exome sequencing (WES) has always been a challenge. In this protocol, we discuss detailed steps from quality check to analysis of the variants using a WES pipeline comparing them with reposited public NGS data and survey different techniques, algorithms and software tools used during each step. We observed that variant calling performed on exome and whole genome datasets have different metrics generated when compared to variant callers, GATK and VarScan with different parameters. Furthermore, we found that VarScan with strict parameters could recover 80-85% of high quality GATK SNPs with decreased sensitivity from NGS data. We believe our protocol in the form of pipeline can be used by researchers interested in performing WES analysis for genetic diseases and any clinical phenotypes.
Figure 1. The pipeline involving three important phases, viz. preprocessing, variant discovery and prioritization of variants

A. Preprocessing the raw data
Quality check: NGS data analysis depends on the raw data control as it provides a quick insight into the quality of the sequences. This will potentially reduce the amount of further downstream analyses with early identification of questionable samples. The ideal base quality scores for Phred (Cock et al., 2010) have paved the way for the best quality scores for GC content (ca. 50% threshold) and the nucleotide distribution across all reads. In our pipeline, we used FastQC (with default Phred = 20 value) as it plots the read depth and quality score besides a host of other statistical inferences.
1. ./fastqc ~/samples/sample1.fastq FastQC generates an HTML formatted report with box plots and graph plots for mean quality scores for sequences, read length and depth along with the intended coverage (see Figure 2) . Copyright Indexing human genome using bowtie2: Bowtie2-build is used to index reference genome which works at high speed and memory efficient way.
2. ./bowtie2-build −u 10 indexes/references/reference.fq reference When the command is expedited, the current directory will contain six new files that all start with reference and end with .1.bt2, .2.bt2, .3.bt2, .4.bt2, .rev.1.bt2, and .rev.2.bt2. While the first four files are the forward strands, the rev files indicate the reverse indexed sequences.
Alignment and post processing of alignment: Bowtie2 is used for short read alignment. What makes bowtie2 interesting is the use of very little RAM with accuracy and modest performance in indexing the alignment (Langmead and Salzberg, 2012) . The mismatch or any sequencing errors or small genetic variation between samples and reference genome could be checked using the following commands: protocol is used to call indels. The sensitivity and range for calling indels are determined by the respective alignments.
2. java -jar VarScan.jar mpileup2indel sample.mpileup > sample.varScan.indel Variant filter: To get rid of false variants call and remove overlapping between SNP and indels, a filtering option is applied on the resultant variant calling files which provide SNV and indels with higher confidence. An option to generate readcount report can also be used with VarScan (see Table 1 ). 
Data analysis
Benchmarking yielded a good recovery rate for validation of variants/ SNPs ( Figures 3, 4 and 5)
while VarScan with default values was found to have highest overall sensitivity with VarScan strict parameters having the lowest overall sensitivity (Figures 6 and 7) . However, we observed that the preprocessing steps have little impact on the final output, with base recalibration step using GATK Unified Genotyper identifying fewer validated SNPs when compared to VarScan. On the other hand, we found that the recovery of exon variants among the exome samples was typically high when compared to the two whole genome datasets ( Figure 5B ). When variant lists were confined to previously observed variants as observed from the benchmark analyses between Sentieon and GATK (Weber et al., 2015) , we observed that the recovery of SNPs with default parameter was found to be considerably good. Whereas changing variant calling criterion especially using VarScan, for example, imposing strict coverage requirement ( Figure 7 ) yielded less numbers of false positives giving the number of bona fide or de novo variants ( Figures 5A and 5B ). This subtly proves that our benchmarking the six WES and two WGS datasets (see Table 2 ) is variable with the capture, sequencing, processing and post-processing/analysis in the human genome and VarScan is comparable with the GATK in terms of identifying the de novo variants (Figures 5A and 5B ). With the wet-lab components of NGS being cumbersome, analyzing the exons or for that matter intronic variants using bioinformatics pipeline is equally challenging. More pictorial representtaions such as density plots (Figure 8 ) are helpful for further interpretation of variants. There must be significant in silico hurdles and organizational steps discussed from time to time and yet at the end of the analysis, one needs to arrive at the fittest in using the discretionary tools. Although technology challenges persist in setting up certain standards and guidelines, the end-user can enhance the pipeline with further tools. In this protocol, we have essentially shown how a WES pipeline can be run using batch file process and the comparison of VarScan over GATK using benchmarked datasets. 
